Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Telix Pharmaceuticals Limited TLX

Set alert

Price alert · TLX

All alert types
9.05 USD -0.01 -0.06%

As of Nov 3, 11:38 AM ET

Bid
9.03 × 2
Ask
9.05 × 6
9.01 Day range 9.09
6.28 52-week range 13.11
YTD
+20.76%
1 year
-12.95%
Open
9.05
Prev close
9.05
Mkt cap
3.07B
Vol
71.06K
Avg vol
323.44K
EPS
0.10
P/E
90.55
Div yield
0.00%
More statistics
Low
9.01
High
9.09
Forward P/E
-338.83
Beta
0.63
Short ratio
0.76
Inst. own
1.02%
Dividend
0.00
Ex-div date
Earnings
Feb 19, 2027
50-d avg
11.05
200-d avg
9.90
1y target
20.45

5D chart

Chart tools
Interval
1m5m15m30m

Signals (68)
NameTimeAgo
MACD: Buy SignalNov 2, 3:05 PM20 hours ago
SMA: BullishNov 2, 3:00 PM20 hours ago
RSI: OversoldNov 2, 2:40 PM20 hours ago
RSI: OversoldNov 2, 2:30 PM21 hours ago
RSI: OversoldNov 2, 2:05 PM21 hours ago
SMA: BearishNov 2, 1:30 PM22 hours ago
SMA: BullishNov 2, 12:15 PM23 hours ago
MACD: Sell SignalNov 2, 10:30 AM1 day ago
SMA: BearishNov 2, 10:20 AM1 day ago
RSI: OverboughtNov 2, 10:10 AM1 day ago
RSI: OverboughtNov 2, 9:30 AM1 day ago
RSI: OversoldOct 30, 3:00 PM3 days ago
MACD: Buy SignalOct 30, 2:45 PM3 days ago
MACD: Sell SignalOct 30, 1:30 PM3 days ago
RSI: OversoldOct 30, 1:25 PM3 days ago
SMA: BullishOct 30, 12:25 PM4 days ago
SMA: BullishOct 30, 12:25 PM4 days ago
SMA: BearishOct 30, 12:00 PM4 days ago
RSI: OversoldOct 30, 12:00 PM4 days ago
SMA: BullishOct 30, 11:50 AM4 days ago

Newest 20 of 68.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 20.45 +126.1% upside
Target (low)
17.91
Target (mean)
20.45
Target (high)
21.94
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy5
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 5
  • 2 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

TLX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.0860.086 – 0.0860.000.0%329.36M+3.6%1
Next quarter0.0860.086 – 0.0860.000.0%318.75M+2.9%1
Current year0.16140.026 – 0.429-0.0299+639.8%1.39B+16.2%5
Next year-0.038-0.051 – -0.0250.1614-123.5%1.57B+13.1%2

Upgrades and downgrades

The latest rating changes

TLX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 21, 2026WedbushReiteratedOutperformOutperform
Sep 25, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 23, 2026WedbushReiteratedOutperformOutperform
Sep 15, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 14, 2026WedbushReiteratedOutperformOutperform
Sep 2, 2026HC Wainwright & Co.ReiteratedBuyBuy
Aug 20, 2026WedbushReiteratedOutperformOutperform
Jul 7, 2026CitigroupMaintainedBuyBuy
Jul 7, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jul 6, 2026WedbushReiteratedOutperformOutperform
Apr 13, 2026WedbushReiteratedOutperformOutperform
Apr 13, 2026HC Wainwright & Co.ReiteratedBuyBuy
Apr 7, 2026WedbushReiteratedOutperformOutperform
Apr 7, 2026HC Wainwright & Co.ReiteratedBuyBuy
Feb 24, 2026CitigroupMaintainedBuyBuy
Jan 21, 2026HC Wainwright & Co.ReiteratedBuyBuy
Dec 22, 2025HC Wainwright & Co.ReiteratedBuyBuy
Sep 23, 2025UBSMaintainedBuyBuy
Sep 18, 2025CitigroupInitiated—Buy
Sep 10, 2025HC Wainwright & Co.MaintainedBuyBuy
Aug 28, 2025JP MorganDowngradeOverweightNeutral
Aug 28, 2025WedbushReiteratedOutperformOutperform
Jul 3, 2025HC Wainwright & Co.Initiated—Buy
Jun 12, 2025WedbushReiteratedOutperformOutperform
Jun 5, 2025WedbushInitiated—Outperform
Jan 27, 2025UBSMaintainedBuyBuy
Nov 15, 2024UBSInitiated—Buy